The NCI Community Oncology Research Program (NCORP) is a national network of cancer care investigators, providers, academia, and other organizations that care for diverse populations in health systems.
The DCP Community Oncology and Prevention Trials Research Group administers this program.
On This Page
- All Headings will automatically be pulled in to this list.
- Do not edit the content on this template.
About NCORP
The program brings cancer clinical trials and control and delivery studies to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.
Grantee Details
No matching Grants were found.
Clinical Trials
| Title Sort descending | Intervention | Sponsor | Status |
|---|---|---|---|
| Reproductive Health Program in Patients With Cancer | Standard practice related to reproductive heath, Training modules, algorithm, referral development | ECOG-ACRIN Cancer Research Group | Active, not recruiting |
| S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000 | selenium, selenium placebo, vitamin E, vitamin E placebo | SWOG Cancer Research Network | Completed |
| S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases | assessment of therapy complications | SWOG Cancer Research Network | Completed |
| S0820, Adenoma and Second Primary Prevention Trial | Eflornithine placebo & sulindac, Eflornithine placebo & sulindac placebo, Eflornithine plus sulindac, eflornithine & sulindac placebo | SWOG Cancer Research Network | Active, not recruiting |
| S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride | assessment of therapy complications, psychosocial assessment and care, quality-of-life assessment | SWOG Cancer Research Network | Completed |
| S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer | Text message reminder | SWOG Cancer Research Network | Completed |
| S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer | acupuncture therapy, sham acupuncture | SWOG Cancer Research Network | Completed |
| S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy | duloxetine hydrochloride, placebo | SWOG Cancer Research Network | Completed |
| S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction | gastrointestinal complications management/prevention, quality-of-life assessment, therapeutic conventional surgery | SWOG Cancer Research Network | Completed |
| S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) | Preventive Intervention, Quality-of-Life Assessment, Questionnaire Administration | SWOG Cancer Research Network | Completed |